Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
Susan J. Ramus(Cancer Institute of New South Wales), Simon A. Gayther(University of Southern California), Jennifer Alsop(Manchester Academic Health Science Centre), Brooke L. Fridley(Children's Mercy Hospital), Julie M. Cunningham(Cancer Research UK), Weiva Sieh(Roswell Park Comprehensive Cancer Center), Ian Jacobs(London Women's Clinic), David V. Conti(University of Southern California), Kunle Odunsi(Roswell Park Comprehensive Cancer Center), Jonathan P. Tyrer(University of Cambridge), Ellen L. Goode(Mayo Clinic in Florida), Natalia Bogdanova(Medizinische Hochschule Hannover), Honglin Song(University of Cambridge), Thilo Dörk(Hannover Re (Germany)), Jane Hayward(Cancer Research UK), David D.L. Bowtell(Garvan Institute of Medical Research), Kathryn Alsop(Peter MacCallum Cancer Centre), Adam N. Rosenthal(University College London), Lindsay Fraser(The University of Melbourne), Alice S. Whittemore(Cancer Registry of Norway), Antonis C. Antoniou(University of Cambridge), Daniel Barrowdale(University of Cambridge), Aleksandra Gentry‐Maharaj(UCL Australia), Ed Dicks(Institute of Cancer Research), Shashi Lele(Cancer Research UK), Christopher B. Anderson(Cancer Research UK), Maria P. Intermaggio(The University of Melbourne), Valerie McGuire(Cargill (Netherlands)), Christopher K. Edlund(University of Southern California), Samantha Poblete(Cancer Research UK), Matthias Dürst(Cancer Research UK), Usha Menon(MRC Clinical Trials Unit at UCL), Beth Y. Karlan(University of Colorado Cancer Center), Paul D.P. Pharoah(Cedars-Sinai Medical Center), Mine S. Cicek(Cancer Research UK), Kirsten B. Moysich(Roswell Park Comprehensive Cancer Center), Patricia Harrington(Roswell Park Comprehensive Cancer Center), Jenny Lester(Cedars-Sinai Medical Center), Susan Philpott(QIMR Berghofer Medical Research Institute), Gillian Mitchell(Peter MacCallum Cancer Centre), Peter Hillemanns(Hochschule Hannover), Lara Sucheston‐Campbell(Roswell Park Comprehensive Cancer Center), Mercedes Jimenez‐Liñan(University of Kansas)
Cited by 441
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
|New England Journal of Medicine|2012|8k
Patterns of somatic mutation in human cancer genomes
|Nature|2007|3.1k
Intraepithelial CD8 <sup>+</sup> tumor-infiltrating lymphocytes and a high CD8 <sup>+</sup> /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
|Proceedings of the National Academy of Sciences|2005|2.4k